Latest Platform Providers News

KneoMedia Limited reported a half-year loss of $1.02 million for H1 FY26, impacted by delayed payments from New York City amid a mayoral transition. The company is preparing for ASX reinstatement and a $3 million capital raise to support growth.

TZ Limited reported a $1.92 million loss for the half-year ending December 2025, with revenues of $5.4 million impacted by delayed US projects and integration challenges from its Keyvision acquisition. The company is banking on large tenders and expanding Microsoft data centre sales to drive recovery.

Stanmore Resources delivered record coal production and strong cash flow in 2025 despite softer market prices, declaring a fully franked dividend and guiding a modest production decline for 2026.

Wrkr Ltd reports a 43% revenue increase to nearly $7 million in H1 FY2026 but also a 75% rise in net loss, while completing a $15 million capital raise and acquiring payroll compliance firm PaidRight.

EZZ Life Science Holdings has secured a four-year exclusive global distribution agreement with Aumake Limited, committing to at least A$10 million in purchases. This partnership aims to accelerate EZZ’s international reach while preserving brand control.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

EPX Limited has secured Wattwatchers Pty Limited through a Deed of Company Arrangement, backed by a $2.14 million placement and a Share Purchase Plan to raise additional funds. This strategic move enhances EPX’s energy monitoring capabilities and recurring revenue streams.

Adherium Limited has reached a pivotal commercial milestone by expanding its Remote Patient Monitoring program across 110 U.S. Allergy Partners clinics, activating nearly 70% of the network and onboarding close to 700 patients in six months.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its Dyspro and Libbo therapies.

Megaport Limited has launched a A$200 million equity raising to fund the acquisition of Latitude.sh, a high-growth Compute-as-a-Service platform, and accelerate its network expansion in India. This strategic move aims to unify network and compute services, enhancing Megaport’s position in the hybrid cloud and AI markets.

EVE Health Group has taken significant strides in commercialising its women’s and men’s health products Dyspro™ and Libbo™, securing regulatory clearances, first patient prescriptions, and raising $1.1 million to support market expansion.